Mechanisms underlying varioux regulation of Ca chammel activity in smooty muscle cells

平滑肌细胞 Cachammel 活性的多种调节机制

基本信息

  • 批准号:
    04671365
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1992
  • 资助国家:
    日本
  • 起止时间:
    1992 至 1993
  • 项目状态:
    已结题

项目摘要

This project was undertaken to elucidate the mechanisms underlying variety oof regulation of Ca channel activity in smooth muscle cells. In previous study, we showed that norepinephrine (NE) reduces Ca current via two distinctive mechanisms ; Ca-dependent inactivation of Ca channels and Ca-independent regulation. In the present study, it was found that Ca-dependent inactivation of Ca channels mechanism in response to NE was much less available in ureter smooth muscle cells than in vas deferens in Ca-independent mechanism in two type of cells may be attributable to NE-induced release of arachidonic acid (AA) which may contribute the reduction of Ca current in cells from vas deferens but not from ureter. Although the decrease in Ca current by exogenously applied AA was large in vas deferens cells, it was not clear that the release of AA contributed to the NE-induced decrease in Ca current. The AA-induced decrease in Ca current was not affected by treatment with inhibitors of cycloxygenas … More e and lipoxygenase. The decrease was. however, partly inhibited by superoxide desmutase, indicating involvement of superoxide anion production from AA.Moreover, it became clear that NE reduced Ca-activated K current more extensively than Ca current. This resulted in the prolongation of action potentiol duration and the potentiation of contraction.The possibility was also examined that the Ca channel activity is increased by significant decrease in atored Ca in the cell after large release. It was found that memvrane excitability was increased and action potentials were more frequently generated after treatment with cyclopiazonic acid which is a novel inhibitor of Ca-pump in sarcoplasmic reticulum. The major mechanism for the CPA-induced change was the inhibition of Ca-activated K current. Although direct evidence indication ghat depletion of intracellular Ca storage sites results in the potentiation of Ca channel activity was not obtained, the possibility is also likely and may contribute to the increase in membrane excitabilyty. Less
本研究旨在阐明不同钙通道活性调控的机制。在以前的研究中,我们发现去甲肾上腺素(NE)通过两种不同的机制来减少钙电流:钙依赖的钙通道失活和钙非依赖性的调节。本研究发现,去甲肾上腺素引起的输尿管平滑肌细胞钙通道失活机制比输精管细胞的钙通道失活机制要弱得多,这两种细胞的钙非依赖性机制可能归因于去甲肾上腺素诱导的花生四烯酸(AA)的释放,这可能是由于去甲肾上腺素导致输精管细胞钙电流的减少,而不是输尿管细胞钙电流的减少。尽管外源性AA对输精管细胞的钙电流有较大的抑制作用,但AA的释放是否参与了去甲肾上腺素引起的钙电流的降低尚不清楚。环氧合酶…抑制剂不影响AA引起的钙电流降低更多的E和脂氧合酶。减少的是。但部分地被超氧化物歧化酶抑制,表明AA参与了超氧阴离子的产生。此外,NE明显比钙电流更广泛地抑制钙激活的钾电流。这导致了动作电位时程的延长和收缩的增强。还研究了在大量释放后,细胞内钙离子显著减少而导致钙通道活动增加的可能性。研究发现,肌浆网钙泵的新型阻断剂--环匹阿松酸处理后,膜的兴奋性增强,动作电位的产生频率增加。CPA引起的改变的主要机制是抑制钙激活的钾电流。虽然没有直接证据表明细胞内钙存储位点的缺失导致钙通道活性的增强,但这种可能性也是可能的,并可能与膜的兴奋性增加有关。较少

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masanori Suzuki, Katsuhiko Muraki, Yuji Imaizumi, and Minoru Watanabe: "Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca^<2+>-pump, reduces Ca^<2+>-dependent K^+ currents in guinea-pig smmoth muscle cells." Br.J.Pharmacol.107. 134-140 (19
Masanori Suzuki、Katsuhiko Muraki、Yuji Imaizumi 和 Minoru Watanabe:“环匹阿尼酸是肌浆网 Ca^<2>-泵的抑制剂,可减少豚鼠平滑肌细胞中 Ca^<2> 依赖性 K^ 电流。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yuji Imaizumi, Satoshi Henmi, Yoshiaki Uyama, Minoru Watanabe, and Yasushi Ohizumi: "Effects of 9-methyl-7-bromoeudistomin D (MBED), a poweful Ca^<2+> releaser, on smooth muscles of the guinea pig. ("Molecular basis of ion channels and receptors involved
Yuji Imaizumi、Satoshi Henmi、Yoshiaki Uyama、Minoru Watanabe 和 Yasushi Ohizumi:“9-甲基-7-bromoeudistomin D (MBED)(一种强大的 Ca^<2> 释放剂)对豚鼠平滑肌的影响。(”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masanori Suzuki et al.: "Cyclopiazonic acid,an inhibitor of the sarcoplasmic reticulum Ca^<2+>-pump,reduces Ca^<2+>-dependent K^+ currents in guinea-pig smooth muscle cells" Br.J.Pharmacol.107. 134-140 (1992)
Masanori Suzuki 等人:“环匹阿尼酸,一种肌浆网 Ca^<2>-泵抑制剂,可减少豚鼠平滑肌细胞中 Ca^<2> 依赖性 K^电流”Br.J.Pharmacol.107
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshiaki Uyama et al.: "Cyclopiazonic acid,an inhibitor of Ca^<2+>-ATPase in Sarcoplasmic reticulum,increases excitability in ileal smooth muscle" Br.J.Pharmacol.110. 565-572 (1993)
Yoshiaki Uyama 等人:“环匹阿尼酸,一种肌浆网 Ca^2-ATP 酶抑制剂,增加回肠平滑肌的兴奋性”Br.J.Pharmacol.110。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshiaki Uyama, Yuji Imaizumi, and Minoru watanabe: "Cyclopiazonic acid, an inhibitor of Ca^<2+>-ATPase in sarcoplasmic reticulum, increases excitability in ileal smooth muscle." Br.J.Pharmacol.110. 565-572 (1993)
Yoshiaki Uyama、Yuji Imaizumi 和 Minoru watanabe:“环匹阿尼酸是肌浆网中 Ca^2-ATP 酶的抑制剂,可增加回肠平滑肌的兴奋性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IMAIZUMI Yuji其他文献

IMAIZUMI Yuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IMAIZUMI Yuji', 18)}}的其他基金

Development of recombinant cell lines dying upon single action potentialoccurrence and the new screening system for compounds acting on ion channels
开发单次动作电位发生时死亡的重组细胞系以及作用于离子通道的化合物的新筛选系统
  • 批准号:
    23659046
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Positive feedback mechanism for the regulation of intracellular Ca2+ concentration and related ion channels as novel drug targets
作为新型药物靶点调节细胞内Ca2+浓度和相关离子通道的正反馈机制
  • 批准号:
    23390020
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel molecular functions of calcium-activated potassium channel as a target of drug development
钙激活钾通道的新分子功能作为药物开发的靶点
  • 批准号:
    20390027
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analyses of calcium-activated potassium channels as novel targets for new drug therapy
钙激活钾通道作为新药治疗新靶点的分析
  • 批准号:
    17390045
  • 财政年份:
    2005
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The regulation of ion channel activity by intracellular Ca2+ dynamics and survey of candidate molecules available for therapy of related diseases
细胞内Ca2动力学对离子通道活性的调节及可用于治疗相关疾病的候选分子的调查
  • 批准号:
    14370786
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
EXPRESSION OF IONIC CHANNELS DURING CARDIOVASCULAR DISEASE
心血管疾病期间离子通道的表达
  • 批准号:
    10044313
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Ca-dependent Cl channel in tracheal smooth muscle and airway hypersensitivity
气管平滑肌和气道过敏中的 Ca 依赖性 Cl 通道
  • 批准号:
    08672526
  • 财政年份:
    1996
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular cloning of a gene involved in serotohin receptor-mediated signal transduction
参与血清素受体介导的信号转导的基因的分子克隆
  • 批准号:
    06807170
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Tuning L-Type Ca Channel Activity in Arterial Smooth Muscle by Kv Channel-Mediated Clustering
通过 Kv 通道介导的聚类调节动脉平滑肌中的 L 型 Ca 通道活性
  • 批准号:
    10210432
  • 财政年份:
    2018
  • 资助金额:
    $ 1.34万
  • 项目类别:
BK(Ca) channel in heart mitochondria
心脏线粒体中的 BK(Ca) 通道
  • 批准号:
    8806591
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
BK(Ca) channel in heart mitochondria
心脏线粒体中的 BK(Ca) 通道
  • 批准号:
    8459912
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
BK(Ca) channel in heart mitochondria
心脏线粒体中的 BK(Ca) 通道
  • 批准号:
    8628868
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
BK(Ca) channel in heart mitochondria
心脏线粒体中的 BK(Ca) 通道
  • 批准号:
    8298046
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
Analysis of Ca channel localized on secretory granules by lipid bilayer that mimics exocytotic sites
通过模拟胞吐位点的脂质双层分析位于分泌颗粒上的 Ca 通道
  • 批准号:
    23590048
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Properties of the L-type Ca^channel and its mutants
L型Ca^通道及其突变体的特性
  • 批准号:
    23790251
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Developmental changes in Ca channel density and single channel conductance at the presynaptic terminal of central nervous system
中枢神经系统突触前末端Ca通道密度和单通道电导的发育变化
  • 批准号:
    23700474
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Anti-MR(mineralocorticoid receptor) effect of dihydropyridine Ca channel blocker.
二氢吡啶 Ca 通道阻滞剂的抗 MR(盐皮质激素受体)作用。
  • 批准号:
    21790897
  • 财政年份:
    2009
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Structural Insight for Ca channel Regulation by Calmodulin
钙调蛋白对 Ca 通道调节的结构洞察
  • 批准号:
    20770110
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了